Bionano Genomics, Inc. (BNGO) stock
BNGONasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 12/3083% below fair value
$0.95+0.01 (+1.29%)
Close on Nov 17, 2026Market cap $11.21MP/E –Yield –
Bionano Genomics price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Bionano Genomics's price to sales ratio was 0.4× on Nov 11, 2026, against 0.6× a year earlier. Over the last 5 years it ranged from 0.2× to 53.7×, with a median of 1.1×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 0.4× | −0.1 |
| 2025 | Dec 31, 2025 | 0.5× | −0.2 |
| 2024 | Dec 31, 2024 | 0.8× | −1.2 |
| 2023 | Dec 29, 2023 | 2.0× | −14.8 |
| 2022 | Dec 30, 2022 | 16.7× | −37.0 |
| 2021 | Dec 31, 2021 | 53.7× | −8.9 |
| 2020 | Dec 31, 2020 | 62.6× | +61.4 |
| 2019 | Dec 31, 2019 | 1.2× | −3.7 |
| 2018 | Dec 31, 2018 | 4.9× | – |
See a number that looks wrong?